S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

AXSM Axsome Therapeutics Inc

76.00

1.81 (2.44%)

May 03 2024 - Closed

Delayed by 15 minutes

Axsome extends losses as Truist cuts target on lack of clarity for depression candidate

To read the full story on Seeking Alpha, click here.

Axsome Therapeutics (NASDAQ:AXSM)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Axsome Therapeutics Charts.

Axsome Therapeutics (NASDAQ:AXSM)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Axsome Therapeutics Charts.

Axsome Therapeutics Inc News

Axsome Therapeutics Recognizes May as Mental Health Awareness Month
Wednesday 1 May 2024 (4 days ago) • GlobeNewswire Inc.

Axsome Therapeutics Highlights Innovative Neuroscience Portfolio at the American Academy of Neurology (AAN) 2024 Annual Meeting
Monday 15 April 2024 (3 weeks ago) • GlobeNewswire Inc.

Axsome Therapeutics to Report First Quarter 2024 Financial Results on May 6
Wednesday 10 April 2024 (4 weeks ago) • GlobeNewswire Inc.

Axsome Therapeutics Initiates ENGAGE Phase 3 Trial of Solriamfetol for the Treatment of Binge Eating Disorder
Monday 1 April 2024 (1 month ago) • GlobeNewswire Inc.

Axsome Therapeutics Announces Results of CRESCENDO Narcolepsy Patient Survey Demonstrating Unmet Needs in Treated Narcolepsy Type 1 Patients
Monday 25 March 2024 (1 month ago) • GlobeNewswire Inc.

Axsome Therapeutics Announces AXS-12 Achieves Primary Endpoint in the SYMPHONY Phase 3 Trial in Narcolepsy
Monday 25 March 2024 (1 month ago) • GlobeNewswire Inc.

Axsome Therapeutics Initiates PARADIGM Phase 3 Trial of Solriamfetol for the Treatment of Major Depressive Disorder
Tuesday 19 March 2024 (2 months ago) • GlobeNewswire Inc.

Axsome Therapeutics to Present at the Leerink Partners Global Biopharma Conference
Tuesday 5 March 2024 (2 months ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 29 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 29 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 29 February 2024 (2 months ago) • Edgar (US Regulatory)

Axsome Therapeutics to Present at the TD Cowen 44th Annual Healthcare Conference
Tuesday 27 February 2024 (2 months ago) • GlobeNewswire Inc.

More Axsome Therapeutics Inc News Articles

Voip Pal Com (QB)

Kraig Biocraft Laborator... (QB)

Code Green Apparel (PK)

TheGlobe com (PK)

Northwest Biotherapeutics (QB)

Cann American (CE)

Digital Brand Media and ... (PK)

Lightwave Logic

Trump Media and Technology

Anavex Life Sciences

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions